Log in to save to my catalogue

Pathway enrichment in genome‐wide analysis of longitudinal Alzheimer's disease biomarker endophenoty...

Pathway enrichment in genome‐wide analysis of longitudinal Alzheimer's disease biomarker endophenoty...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11667536

Pathway enrichment in genome‐wide analysis of longitudinal Alzheimer's disease biomarker endophenotypes

About this item

Full title

Pathway enrichment in genome‐wide analysis of longitudinal Alzheimer's disease biomarker endophenotypes

Publisher

United States: John Wiley and Sons Inc

Journal title

Alzheimer's & dementia, 2024-12, Vol.20 (12), p.8639-8650

Language

English

Formats

Publication information

Publisher

United States: John Wiley and Sons Inc

More information

Scope and Contents

Contents

INTRODUCTION
The genetic pathways that influence longitudinal heterogeneous changes in Alzheimer's disease (AD) may provide insight into disease mechanisms and potential therapeutic targets.
METHODS
Longitudinal endophenotypes from the Alzheimer's Disease Neuroimaging Initiative (ADNI) representing amyloid, tau, neurodegeneration (A/T/N),...

Alternative Titles

Full title

Pathway enrichment in genome‐wide analysis of longitudinal Alzheimer's disease biomarker endophenotypes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11667536

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11667536

Other Identifiers

ISSN

1552-5260,1552-5279

E-ISSN

1552-5279

DOI

10.1002/alz.14308

How to access this item